Medical Term for Elevated Hemoglobin, RBC Count, and Hematocrit
The medical term for elevated hemoglobin, red blood cell count, and hematocrit is "polycythemia" or "erythrocytosis" - these terms are used interchangeably to describe an increase in red cell parameters 1, 2.
Key Terminology Distinctions
Polycythemia specifically refers to the condition where hemoglobin, hematocrit, and/or red cell mass are elevated above normal reference ranges. The WHO diagnostic criteria for Polycythemia Vera (PV) - the most clinically significant form - define this as:
- Hemoglobin > 16.5 g/dL in men or > 16 g/dL in women
- Hematocrit > 49% in men or > 48% in women 3
These thresholds represent pathologic elevation requiring diagnostic workup 1.
Clinical Context Matters
The term "erythrocytosis" is often used more broadly and can indicate either:
- Primary erythrocytosis: Clonal myeloproliferative disorder (like Polycythemia Vera with JAK2 mutations)
- Secondary erythrocytosis: Reactive increase due to hypoxia, smoking, sleep apnea, or other causes 2
Important caveat: Not all elevated red cell parameters indicate true polycythemia. The 2016 WHO criteria lowered diagnostic thresholds, which means 5.99% of men and 0.28% of women with "normal" complete blood counts now meet hemoglobin/hematocrit criteria for PV 4. This creates substantial overlap with physiologic variation, making clinical context and additional testing (particularly JAK2 mutation analysis) essential to distinguish pathologic from benign elevation 2, 4.
Rare Presentation Alert
Be aware that "masked polycythemia" exists - patients with underlying PV who present with normal hemoglobin/hematocrit due to blood dilution or concurrent blood loss, yet still harbor JAK2 mutations and thrombotic risk 5. Additionally, macrocytosis (elevated MCV) can artificially elevate hemoglobin/hematocrit levels, mimicking polycythemia 6.